Retinoic acid regulates myelin formation in the peripheral nervous system

GLIA

Volumn 58, Issue 12, 2010, Pages 1451-1464

  Latasa, Maria Jesus ^a   Ituero, Mario ^a   Moran Gonzalez, Alejandra ^a   Aranda, Ana ^a   Cosgaya, Jose Miguel ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

DRG neuron; Krox 20; Schwann cell; Sciatic nerve

Indexed keywords

MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; MYELIN PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; 4-(2-(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)-1-PROPENYL)BENZOIC ACID; 6 [1 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL)CYCLOPROPYL]NICOTINIC ACID; ANTINEOPLASTIC AGENT; AZO COMPOUND; BAX-INHIBITING PEPTIDE, BIP; BENZOIC ACID DERIVATIVE; EARLY GROWTH RESPONSE FACTOR 2; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MESSENGER RNA; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN H; NICOTINIC ACID DERIVATIVE; OLIGOPEPTIDE; PROTEIN BINDING; RETINOID; SIGNAL PEPTIDE; SUDAN BLACK B; TETRALIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DOWN REGULATION; EMBRYO; GENE OVEREXPRESSION; MOUSE; MYELINATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SCIATIC NERVE; UPREGULATION; AGE; ANIMAL; ANIMAL EMBRYO; ANTAGONISTS AND INHIBITORS; CELL CULTURE; COCULTURE; CYTOLOGY; DIAGNOSTIC USE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MYELIN SHEATH; NERVE CELL; NEWBORN; PHYSIOLOGY; SCHWANN CELL; SPINAL GANGLION; WISTAR RAT;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTINEOPLASTIC AGENTS; AZO COMPOUNDS; BENZOATES; CELLS, CULTURED; COCULTURE TECHNIQUES; EARLY GROWTH RESPONSE PROTEIN 2; EMBRYO, MAMMALIAN; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MYELIN PROTEINS; MYELIN SHEATH; NEUROFILAMENT PROTEINS; NEURONS; NICOTINIC ACIDS; OLIGOPEPTIDES; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; RNA, MESSENGER; SCHWANN CELLS; SCIATIC NERVE; TETRAHYDRONAPHTHALENES; TRANSCRIPTION FACTOR CHOP; TRETINOIN;

EID: 77956602967     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21020     Document Type: Article

References (45)

1. Aranda A, Pascual A. 2001. Nuclear hormone receptors and gene expression. Physiol Rev 81:1269-1304. (Pubitemid 32606670)
2. Aström A, Pettersson U, Krust A, Chambon P, Voorhees JJ. 1990. Retinoic acid and synthetic analogs differentially activate retinoic acid receptor dependent transcription. Biochem Biophys Res Commun 173:339-345.
3. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. 1995. Embryonic stem cells express neuronal properties in vitro. Dev Biol 168:342-357.
4. Barisic N, Claeys KG, Sirotković-Skerlev M, Löfgren A, Nelis E, De Jonghe P, Timmerman V. 2008. Charcot-Marie-Tooth disease: A clinico- genetic confrontation. Ann Hum Genet 72(Pt 3):416-441.
5. Barres BA, Lazar MA, Raff MC. 1994. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120:1097-1108.
6. Boehm MF, Zhang L, Zhi L, McClurg MR, Berger E, Wagoner M, Mais DE, Suto CM, Davies JA, Heyman RA. 1995. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J Med Chem 38:3146-3155.
7. Cañón E, Cosgaya JM, Scsucova S, Aranda A. 2004. Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells. Mol Biol Cell 15:5583-5592.
8. Carenini S, Montag D, Schachner M, Martini R. 1998. MAG-deficient Schwann cells myelinate dorsal root ganglion neurons in culture. Glia 22:213-220.
9. Chan JR, Cosgaya JM, Wu YJ, Shooter EM. 2001. Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc Natl Acad Sci USA 98:14661-14668.
10. Corcoran J, Maden M. 1999. Nerve growth factor acts via retinoic acid synthesis to stimulate neurite outgrowth. Nat Neurosci 2:307-308.
11. NTR as a positive modulator of myelination. Science 298:1245-1248.
12. Cosgaya JM, Garcia-Villalba P, Perona R, Aranda A. 1996. Comparison of the effects of retinoic acid and nerve growth factor on PC12 cell proliferation, differentiation, and gene expression. J Neurochem 66:89-98. (Pubitemid 26010768)
13. Cosgaya JM, Perona R, Aranda A. 1997. Retinoic acid induces secretion of transforming growth factors by PC12 pheochromocytoma cells. Oncogene 14:579-587.
14. Diez del Corral R, Storey KG. 2004. Opposing FGF, retinoid pathways: A signalling switch that controls differentiation and patterning onset in the extending vertebrate body axis. Bioessays 26:857-869.
15. Garbay B, Heape AM, Sargueil F, Cassagne C. 2000. Myelin synthesis in the peripheral nervous system. Prog Neurobiol 61:267-304.
16. Haussler M, Sidell N, Kelly M, Donaldson C, Altman A, Mangelsdorf D. 1983. Specific high-affinity binding and biologic action of retinoic acid in human neuroblastoma cell lines. Proc Natl Acad Sci USA 80:5525-5529. (Pubitemid 14242881)
17. Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Sabéran-Djoniedi D, Figarella-Branger D, Pellissier JF, Thomas PK, et al. 1998. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 7:449-458.
18. -/- mutant mice are viable. Proc Natl Acad Sci USA 93:9010-9014.
19. Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci USA 102:2596-2601.
20. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerly W, Trapp BD, Peterson A, Roder J. 1994. Myelination in the absence of myelin-associated glycoprotein. Nature 369:747-750.
21. Lin W, Popko B. 2009. Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci 12:379-385.
22. Maden M. 2007. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 8:755-765.
23. Mey J, Schrage K, Wessels I, Vollpracht-Crijns I. 2007. Effects of inflammatory cytokines IL-1β, IL-6, and TNFα on the intracellular localization of retinoid receptors in Schwann cells. Glia 55:152-164.
24. Montag D, Giese KP, Bartsch U, Martini R, Lang Y, Blüthmann H, Karthigasan J, Kirschner DA, Wintergerst ES, Nave KA. 1994. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13:229-246. (Pubitemid 24238427)
25. Murphy P, Topilko P, Schneider-Maunoury S, Seitanidou T, Baron-Van Evercooren A, Charnay P. 1996. The regulation of Krox-20 expression reveals important steps in the control of peripheral glial cell development. Development 122:2847-2857.
26. Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J. 2001. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30:355-368.
27. Niemann S, Sereda MW, Suter U, Griffiths IR, Nave KA. 2000. Uncoupling of myelin assembly and schwann cell differentiation by trans- genic overexpression of peripheral myelin protein 22. J Neurosci 20:4120-4128.
28. Nobbio L, Vigo T, Abbruzzese M, Levi G, Brancolini C, Mantero S, Grandis M, Benedetti L, Mancardi G, Schenone A. 2004. Impairment of PMP22 transgenic Schwann cells differentiation in culture: Implications for Charcot-Marie-Tooth type 1A disease. Neurobiol Dis 16:263-273.
29. Noll E, Miller RH. 1994. Regulation of oligodendrocyte differentiation: A role for retinoic acid in the spinal cord. Development 120:649-660.
30. Owens GC, Boyd CJ, Bunge RP, Salzer JL. 1990. Expression of recombinant myelin-associated glycoprotein in primary Schwann cells promotes the initial investment of axons by myelinating Schwann cells. J Cell Biol 111:1171-1182.
31. Owens GC, Bunge RP. 1991. Schwann cells infected with a recombinant retrovirus expressing myelin-associated glycoprotein antisense RNA do not form myelin. Neuron 7:565-575.
32. Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL. 2005. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS, PNS: Neuropathology and behavioral deficits in single- and doublenull mice. Exp Neurol 195:208-217.
33. Pennuto M, Tinelli E, Malaguti M, Del Carro U, D'antonio M, Ron D, Quattrini A, Feltri ML, Wrabetz L. 2008. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron 57:393-405.
34. Robaglia-Schlupp A, Pizant J, Norreel JC, Passage E, Sabéran- Djoneidi D, Ansaldi JL, Vinay L, Figarella-Branger D, Lévy N, Clarac F, et al. 2002. PMP22 overexpression causes dysmyelination in mice. Brain 125(Pt 10):2213-2221.
35. Scheibe RJ, Ginty DD, Wagner JA. 1991. Retinoic acid stimulates the differentiation of PC12 cells that are deficient in cAMP-dependent protein kinase. J Cell Biol 113:1173-1182.
36. Svaren J, Meijer D. 2008. The molecular machinery of myelin gene transcription in Schwann cells. Glia 56:1541-1551.
37. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Charnay P. 1994. Krox-20 controls myelination in the peripheral nervous system. Nature 371:796-799.
38. Trapp BD, Quarles RH. 1982. Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin. J Cell Biol 92:877-882.
39. Wang L, Mear JP, Kuan CY, Colbert MC. 2005. Retinoic acid induces CDK inhibitors and growth arrest specific (Gas) genes in neural crest cells. Dev Growth Differ 47:119-130.
40. Wrabetz L, D'Antonio M, Pennuto M, Dati G, Tinelli E, Fratta P, Previtali S, Imperiale D, Zielasek J, Toyka K, et al. 2006. Different intracellular pathomechanisms produce diverse myelin protein zero neuropathies in transgenic mice. J Neurosci 26:2358-2368.
41. Wrabetz L, Feltri ML, Quattrini A, Imperiale D, Previtali S, D'Antonio M, Martini R, Yin X, Trapp BD, Zhou L, et al. 2000. P0 glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 148:1021-1034.
42. 0 protein. J Cell Biol 148:1009-1020.
43. Zhelyaznik N, Mey J. 2006. Regulation of retinoic acid receptors α, β and retinoid X receptor a after sciatic nerve injury. Neuroscience 141:1761-1774.
44. Zhelyaznik N, Schrage K, McCaffery P, Mey J. 2003. Activation of retinoic acid signalling after sciatic nerve injury: Up-regulation of cellular retinoid binding proteins. Eur J Neurosci 18:1033-1040.
45. Zorick TS, Syroid DE, Brown A, Gridley T, Lemke G. 1999. Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development 126:1397-1406. (Pubitemid 29195229)